Although there is a mounting body of evidence that eosinophils are recruited to sites of allergic inflammation by a number of ~-chemokines, particularly eotaxin and RANTES, the receptor that mediates these actions has not been identified. We have now cloned a G protein-coupled receptor, CC CKR3, from human eosinophils which, when stably expressed in AML14.3D10 cells bound eotaxin, MCP-3 and R_ANTES with Kas of 0.1, 2.7, and 3.1 nM, respectively. CC CKR3 also bound MCP-1 with lower affinity, but did not bind MIP-10~ or MIP-I[~. Eotaxin, RANTES, and to a lessor extent MCP-3, but not the other chemokines, activated CC CKR3 as determined by their ability to stimulate a CaZ+-flux. Competition binding studies on primary eosinophils gave binding at~inities for the different chemokines which were indistinguishable from those measured with CC CKR3. Since CC CKR3 is prominently expressed in eosinophils we conclude that CC CKR3 is the eosinophil eotaxin receptor. Eosinophils also express a much lower level of a second chemokine receptor, CC CKR1, which appears to be responsible for the effects of MIP-llx.
osinophils play prominent roles in a variety of atopic conditions including allergic rhinitis, dermatitis, conjunctivitis, and bronchial asthma (1, 2) . A pivotal event in the process is the accumulation of eosinophils at the involved sites. While a number of the classical chemoattractants, including CSa, LTB4, and PAF, are known to attract eosinophils (1), these mediators are promiscuous, acting on a variety ofleukocytes including neutrophils, and are unlikely to be responsible for the selective accumulation of eosinophils. In contrast, the [3-chemokines, a family of 8-10-kD secreted proteins, are more restricted in the leukocyte subtypes they target (3), and studies from a variety of laboratories have implicated several as candidates for the recruitment of eosinophils in atopic diseases. In particular, RANTES, MCP-3, MIP-lo~, and most recently, eotaxin, have been shown to activate eosinophils in vitro (4) (5) (6) , and RANTES and eotaxin to selectively attract eosinophils in vivo (7, 8) . Moreover, eotaxin is generated during antigen challenge in the guinea pig model of allergic airway inflammation (9, 10) .
While elucidation of the actions of [3-chemokines on eosinophils has contributed greatly to our understanding of eosinophil biology, information regarding the cell surface receptors that mediate these effects remains sparse. The known ~-chemokine receptors are members of the G protein-coupled receptor superfamily. Although two of these receptors, CC CKR1 (11-13, Daugherty, B., manuscript in preparation) and CC CKR2 (MCP-1R) (14-16) have been extensively characterized, neither has the necessary ligand selectivity or the appropriate expression patterns to mediate the effects of the [3-chemokines on eosinophils. Therefore, we initiated an effort to identify and characterize eosinophil-specific chemokine receptors. In this report we describe the properties of a third [~-chemokine receptor, CC CKR3, cloned from primary eosinophils, and functionally expressed in AML14.3D10 cells. This receptor has the expected ligand specificity as it binds the potent eosinophil attractants, eotaxin, RANTES, and MCP-3 with high affinity. Correlation with the binding properties of primary eosinophils provides compelling evidence that CC CKR3 is the primary endogenous receptor that mediates the effects of B-chemokines on eosinophils. Eosinophils also express a much lower level of CC CKR1, a receptor that appears to be responsible for the effects of MIP-lo~.
Assays. Recombinant chemokines were obtained from PeproTech (Rocky Hill, NJ). ~2SI-MCP-3 and ~2SI-MIP-lo~ was obtained from DuPont NEN (Boston, MA) and ~25I-human-eotaxin from Amersham (Arlington Heights, IL). Binding of ~25I-labeled ligands (typically a total of 2 • 104 cpm) in the presence of varying concentrations of unlabeled ligands to intact cells (typically 1.5 • 104 , 10 s, or 106 for experiments with labeled eotaxin, MCP-3, or MIP-la, respectively) were performed at 32~ as described (25) . Ligand-induced Ca ~+ fluxes in transfected AML14.3D10 cells were performed with indo-1 as described (25) .
Results and Discussion
Orphan Cloning of an Eosinophil ~-Chemokine Receptor.
The previously characterized ~3-chemokine receptors, CC CKR1 (11) and CC CKR2 (14) , share substantial homology in transmembrane helices II and VII. Using an P,T/ PCR strategy based on this homology, we cloned a novel open reading frame from total human eosinophil RNA which codes for a protein of 355 amino acids. The sequence of this protein, designated CC CKt<3, is 63% and 51% identical to CC CKR1, and CC CKR2B, its two closest homologues ( Fig. 1 ). This sequence is also identical to that reported by Combadiere et al. (26) except that it contains a lysine in place of asparagine at position 107. We have confirmed our sequence by analysis of genomic clones. The discrepancy is unlikely to be due to genetic polymorphisrn since all or-and [~-chemokine receptors analyzed to date contain lysine in that position including the recently described basophilic [3-chemokine receptor (27) , CC CKR1 (11), MCP-1R (14) , IL-8RA and IL-8RB (28, 29) , the three murine [3-chemokine receptors (30, 31) as well as three human chemokine-like receptors (32) (33) (34) (Fig. 3 a, Table 1 ). In contrast, M C P -1 c o mpeted with m u c h lower affinity (Ka = 60 nM), and M I Plot, MIP-1[3 ( Fig. 3 a, Table 1 ), and the cx-chemokine, IL-8 (data not shown), failed to compete at all. 
Binding to CC CKR3 on Intact A M L 1 4 / C C C K R
3 . 1 6 Cells. C o m p e t i t i o n b i n d i n g studies were performed with 125I-eotaxin o n clone 3.16 in order to characterize the pharmacological properties of C C CKtL3. As s h o w n in Fig. 3 a and Table 1, unlabeled h u m a n and m u r i n e eotaxin both competed with Kas of 0.1 nM. Scatchard analysis d e m o nstrated that the eotaxins b o u n d with a single affinity and that clone 3.16 expressed 4 X 105 receptors/cell (data not shown). This activity is due to C C CKR.3 since neither n o n i m m unoreactive clones, such as 3.49, n o r untransfected cells displayed any specific b i n d i n g (data n o t shown). Clearly, C C CKIL3 is a high affinity receptor for eotaxin. Cross-competition studies with other [3-chemokines k n o w n to be p otent eosinophil chemoattractants, M C P -3 and R A N T E S , demonstrated that they b o u n d to C C CKtL3 with Kas of about 3 n M
T a b l e 1. Binding Affinities of Various Chemokines Comparing CC CKR3 Expressed in AML14.3010 with Primary Eosinophils
Competition binding experiments were carried out against the indicated iodinated ligand as described in the legend of Fig. 2 and in Materials and Methods. All results are the averages of the number of experiments shown in parenthesis. KdS were calculated using LIGAND (36) . N.B., no competition was observed.
Competition binding studies were also carried out against 12SI-MCP-3. Again, human and murine eotaxin competed strongly with Kas of 0.2 and 0.3 nM, respectively (Fig 3 b , Table 1 ). MCP-3 and RANTES also demonstrated high affinity, with KdS of 0.7 and 0.5 nM, values about fourfold lower than measured against 12SI-eotaxin. MCP-1 competed weakly (Ka = 16 nM), and MIP-l~x, and MIP-113 failed to compete at all. Thus, despite small quantitative differences, the overall ligand selectivity of the receptor is the same whether measured by competition against eotaxin or MCP-3, and the order of potency, eotaxin>MCP-3 = RANTES>>MCP-1, is identical.
CC CKR3 Is Functionally Coupled in AML14.3D10 Cells.
To determine whether CC CKR3 was functionally coupled in AML14.3010 cells, intracellular Ca 2+ levels were measured in response to various 13-chemokines. As shown in Fig. 4 , eotaxin and RANTES induced Ca2+-fluxes in cells expressing the receptor with EDs0s of 0.3 and 10 nM, values consistent with their binding affinities. Surprisingly, 100 nM of MCP-3 was required to induce a response, and that response was smaller than those observed for eotaxin or RANTES (Fig. 4) . No response was generated by the addition ofMIP-lo~, MIP-1[3, MCP-1 or IL-8 at concentrations as high as 1 txM (data not shown)L The responses to eotaxin, RANTES, and MCP-3 are due to the specific expression of CC CKR3 since none of these mediators induced fluxes in untransfected cells (data not shown), or in clone 3.49 (negative control; Fig. 4 ).
Binding Properties of Pn'mary Eosinophils. The selectivity of CC CKR3 for the various 13-chemokines mirrors the effectiveness of these ligands as eosinophil chemoattractants suggesting that CC CKR.3 is the primary mediator ofchemokine I Combadiere et al. (26) have reported cloning a receptor that differs by only one amino acid from the sequence reported in the present communication. While their very preliminary functional characterization differs greatly from ours, they were unable to demonstrate any specific binding to cells putatively expressing the receptor, and their functional data have now been retracted (35) .
,.g induced eosinophil chemotaxis. To provide additional pharmacological evidence we conducted binding studies on primary eosinophils. When measured by competition against 12SI-eotaxin, unlabeled human eotaxin gave a Kd of 0.1 nM, a value identical to that obtained on cloned CC CK1K3 (Fig. 3 c, Table 1 ). Scatchard analysis showed a single binding affinity, and 4 X 10 5 sites/cell averaged over three donors (data not shown). The affinities for RANTES and MCP-3 were indistinguishable from those measured on CC CKR3, and as with CC CKIL3, MIP-lo~ and MIP-II3 did not exhibit any ability to compete with radiolabeled eotaxin (Fig. 3 , a and c, Table 1 ). Similarly, the Kas obtained by competition against lesI-MCP-3 on eosinophils were within twofold of those measured against cloned CC CKIK3 (Fig. 3, b and d, Table 1 ). All of the observations and measurements, taken together with the Western blots (Fig. 2) showing expression ofCC CK1K3, verify that CC CK1K3 is the eosinophil eotaxin receptor, and appears to be largely responsible for mediating the effects of most [3-chemokines on eosinophils.
Eosinophils Also Express CC CKR1 at Low Levels. One difference between data obtained with eosinophils and that with cloned CC CKR3 is that MIP-lci partially inhibited the binding of 125I-MCP-3 on eosinophils (Fig. 3 d) . To invesfgate the nature of the site responsible for these effects, detailed studies were carried out by competition against 125I-MIP-lci. As shown in Fig. 5 , MIP-1oq MCP-3, and RANTES all competed strongly with ICs0s of 0.3, 0.7, and 0.9 riM, respectively. In contrast, human and routine eotaxin competed with relatively low affinity, showing ICs0s of 45 and ll nM, respectively, while the affinity of MCP-1 is even lower with an IC50 of 120 nM. These pharmacological characteristics are clearly distinct from those of CC CKR3, but are identical to those we have reported for CC CKR1 expressed in RBL2H3 cells (Daugherty, B., manuscript in preparation). Scatchard analysis shows 0.5-2 • 104 sites/cell, only 1-5% the level of CC CKR3 (data not shown).
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._o 80 The properties of CC CKR.3 and CC CKR1 can account for the reported effects of ~-chemokines on eosinophils. As discussed above, the data strongly support the conclusion that CC CKR3 is the eotaxin receptor. While the properties of the two receptors indicate that either is capable of mediating the activity of RANTES and MCP-3, CC CKR3 is probably the primary transducer since it is expressed at 20-80 times the level of CC CKR.1 (4 • 10 s vs. 0.5-2 • 104 sites/cell), a difference that more than compensates for the greater affimty of CC CKI~I for the two chemokines. MIP-lct must act through CC CKR.1 as it binds strongly to and activates this receptor (11, Daugherty, B., manuscript in preparation), but does not bind to CC CKR3. The identification of the two [3-chemokine eosinophil receptors is consistent with predictions made from heterologous desensitization experiments. Based on these studies Dahinden et al. (4) postulated the existence of two receptors, one that is actwated by R.ANTES and MCP-3, and a second that is activated by MIP-I~, R.ANTES, and by MCP-3. Although those studies predate the discovery of eotaxin, the properties of the first receptor are consistent with CC CK_R3, and those of the second with CC CKIL1.
CC CKR3 is the third [3-chemokine receptor to be extensively characterized, and like CC CKR1 and CC CKR2 it binds and is acuvated by multiple ligands. The selectivities of the three receptors overlap, but are not identical: CC CKR1 binds MCP-3, R.ANTES, and MIP-lot (11-13, Daugherty, B., manuscript m preparation), CC CKR2 binds MCP-1 and MCP-3 (14, 16) , and CC CKR3 is selective for eotaxin, R_ANTES and MCP-3. While there as little correlation between overall sequence homology of the [3-chemokines and the receptors they target, local motifs must exist which control specificity. Elucidation of those motifs should significantly advance structurally based approaches to develop selective antagonists for the different receptors.
